184 related articles for article (PubMed ID: 25483074)
1. HMGA1-pseudogene overexpression contributes to cancer progression.
Esposito F; De Martino M; Forzati F; Fusco A
Cell Cycle; 2014; 13(23):3636-9. PubMed ID: 25483074
[TBL] [Abstract][Full Text] [Related]
2. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
[TBL] [Abstract][Full Text] [Related]
3. HMGA1-pseudogene expression is induced in human pituitary tumors.
Esposito F; De Martino M; D'Angelo D; Mussnich P; Raverot G; Jaffrain-Rea ML; Fraggetta F; Trouillas J; Fusco A
Cell Cycle; 2015; 14(9):1471-5. PubMed ID: 25894544
[TBL] [Abstract][Full Text] [Related]
4. HMGA1-pseudogenes and cancer.
De Martino M; Forzati F; Arra C; Fusco A; Esposito F
Oncotarget; 2016 May; 7(19):28724-35. PubMed ID: 26895108
[TBL] [Abstract][Full Text] [Related]
5. HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.
Andreozzi M; Quintavalle C; Benz D; Quagliata L; Matter M; Calabrese D; Tosti N; Ruiz C; Trapani F; Tornillo L; Fusco A; Heim MH; Ng CK; Pallante P; Terracciano LM; Piscuoglio S
Neoplasia; 2016 Dec; 18(12):724-731. PubMed ID: 27855356
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Axis of miR-195/497 and HMGA1-Id3 Governs Muscle Cell Proliferation and Differentiation.
Qiu H; Zhong J; Luo L; Tang Z; Liu N; Kang K; Li L; Gou D
Int J Biol Sci; 2017; 13(2):157-166. PubMed ID: 28255268
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
[TBL] [Abstract][Full Text] [Related]
8. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes.
Chiefari E; Iiritano S; Paonessa F; Le Pera I; Arcidiacono B; Filocamo M; Foti D; Liebhaber SA; Brunetti A
Nat Commun; 2010 Jul; 1():40. PubMed ID: 20975707
[TBL] [Abstract][Full Text] [Related]
9. Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.
Shang J; Wang Z; Chen W; Yang Z; Zheng L; Wang S; Li S
J Cell Physiol; 2019 Aug; 234(8):13735-13746. PubMed ID: 30623445
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
[TBL] [Abstract][Full Text] [Related]
11. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
12. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Liau SS; Jazag A; Ito K; Whang EE
Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
[TBL] [Abstract][Full Text] [Related]
15. The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism.
De Martino M; Palma G; Azzariti A; Arra C; Fusco A; Esposito F
Genes (Basel); 2017 Nov; 8(11):. PubMed ID: 29149041
[TBL] [Abstract][Full Text] [Related]
16. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
[TBL] [Abstract][Full Text] [Related]
17. MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Tian X; Song J; Zhang X; Yan M; Wang S; Wang Y; Xu L; Zhao L; Wei JJ; Shao C; Kong B; Liu Z
Cell Death Dis; 2020 Mar; 11(3):167. PubMed ID: 32127525
[TBL] [Abstract][Full Text] [Related]
18. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
19. A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy.
Hassan F; Lossie SL; Kasik EP; Channon AM; Ni S; Kennedy MA
PLoS One; 2018; 13(2):e0192882. PubMed ID: 29462157
[TBL] [Abstract][Full Text] [Related]
20. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
